$39.31
-0.21 (-0.53%)
Eli Lilly & Co. (NYSE:LLY)
CAPS Rating:
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
RSS Headlines
Fool UK